SCHEMBL45736

SCHEMBL45736

c1cncc(-c2cc(-c3cccnc3)cc(-n3c4ccc(-n5c6ccccc6c6ccccc65)cc4c4cc(-n5c6ccccc6c6ccccc65)ccc43)c2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP11B2 P19099 3/20 0.42
▸ CYP1A2 P05177 2/20 0.42
▸ CYP2A6 P11509 2/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP11B1 P15538 2/20 0.40
▸ MAPT P10636 7/20 0.40
▸ METAP2 P50579 1/20 0.39
▸ CYP19A1 P11511 2/20 0.39
▸ CYP17A1 P05093 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ ATM Q13315 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ GLO1 Q04760 1/20 0.38
▸ KCNH2 Q12809 1/20 0.38
▸ AOC3 Q16853 1/20 0.38
▸ DHFR P00374 1/20 0.38
▸ RAC2 P15153 1/20 0.38
▸ RAC3 P60763 1/20 0.38
▸ CDC42 P60953 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31732139 0.93 KDM4E (0.41) CYP11B2CYP1A2CYP2A6ALDH1A1CYP3A4
SCHEMBL18701153 0.92 MAPT (0.44) CYP11B2CYP1A2CYP2A6ALDH1A1CYP3A4
SCHEMBL15153866 0.92 MAPT (0.44) CYP11B2CYP1A2CYP2A6ALDH1A1CYP3A4
SCHEMBL19654636 0.90 KDM4E (0.43) CYP11B2CYP1A2CYP2A6ALDH1A1CYP3A4
SCHEMBL24493058 0.90 MEN1 (0.46) CYP11B2CYP1A2CYP2A6ALDH1A1CYP3A4
SCHEMBL15074076 0.89 KDM4E (0.40) CYP11B2CYP1A2ALDH1A1MAPTMETAP2
SCHEMBL31663551 0.89 CYP11B2 (0.43) CYP11B2CYP1A2CYP2A6ALDH1A1CYP3A4
SCHEMBL15159283 0.89 MAPT (0.42) CYP11B2CYP1A2CYP2A6CYP3A4CYP11B1
SCHEMBL16362426 0.88 CYP11B1 (0.42) CYP11B2CYP1A2CYP2A6ALDH1A1CYP3A4
SCHEMBL15073545 0.88 CYP11B1 (0.42) CYP11B2CYP1A2CYP2A6ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10644243-B2 N-phenyl triscarbazole NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2020-05-05 — — US disclosed
EP-2609080-B1 N-PHENYL TRISCARBAZOLE SOLVAY (BE) 2016-03-30 — — EP disclosed
WO-2012025510-A1 N-PHENYL TRISCARBAZOLE SOLVAY SA (BE) 2012-03-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10644243-B2 N-phenyl triscarbazole RB1, LBR, NR1I2 CYP11B2 882/4885CYP1A2 353/4885CYP2A6 1616/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback